Stock 603707 NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

Equities

603707

CNE100002WP3

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-19 pm EDT 		5-day change 1st Jan Change
13.75 CNY -0.43% Intraday chart for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. -0.58% -8.33%
May. 13 NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US MT
May. 01 NKFPharma Gets Nod to Register New Cancer Treatment MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nanjing King Friend Biochemical Pharmaceutical : Meitheal Pharmaceuticals Announces FDA Approval of Additional Manufacturing Capacity and Future Facility Expansion Plans for Production of Heparin Sodium Injection USP
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603707 Stock
  4. News Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
  5. Press Releases
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW